University of Laval, Ste-Foy
Recent findings from Canada and the United States illuminate research in lipids
Published in Physician Law Weekly, August 9th, 2006
Study 1: Plasma apolipoprotein-B levels modulated the risk of coronary heart disease associated with low-density lipoprotein cholesterol over a 13-year follow-up.
According to recent research from Canada, "We examined whether plasma apolipoprotein-B (apo-B) levels add further information on the risk of coronary heart disease (CHD) after taking into account low-density lipoprotein (LDL) cholesterol concentrations and other traditional risk factors."
"Among 2,072 CHD-free men from the Quebec Cardiovascular Study at entry and followed for 13 years, 230 had...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2006-08-09)
More Articles from Physician Law Weekly
- Biovail
Biovail appoints general counsel - DUSA Pharmaceuticals
DUSA Pharmaceuticals sues additional physicians and a chemical supplier for patent infringement - Finance
MediConnect closes major funding round, adds three members to board of directors - H. Lundbeck
H. Lundbeck and Forest sue Caraco Pharmaceutical Laboratories for patent infringement - Medegen
Madigan files patent infringement suit against ICU Medical on luer-activated valve technology - Medicaid
Medicaid launches effort to combat fraud and abuse - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
